AI-Generated Enzymes Market Size, Share, Trends, Industry Analysis Report: By Type (Industrial Enzymes, Therapeutic Enzymes, and Others), Application, Technology, End User, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) – Market Forecast, 2025 - 2034
- Published Date:Apr-2025
- Pages: 128
- Format: PDF
- Report ID: PM5543
- Base Year: 2024
- Historical Data: 2020-2023
AI-Generated Enzymes Market Overview
The global AI-generated enzymes market size was valued at USD 2,241.00 million in 2024. The market is projected to grow from USD 2,771.89 million in 2025 to USD 19,407.75 million by 2034, exhibiting a CAGR of 24.1% during the forecast period.
The AI-generated enzymes market refers to the industry focused on the development and commercialization of enzymes optimized using artificial intelligence (AI) for applications in pharmaceuticals, biofuels, food processing, and industrial biotechnology. The market is expanding rapidly due to the increasing adoption of AI-driven solutions that accelerate enzyme discovery and enhance efficiency. One of the major drivers is the rising demand for sustainable and cost-effective biocatalysts, as AI-generated enzymes offer superior precision and functionality compared to traditional enzymes. Additionally, advancements in AI-powered protein engineering are driving AI-generated enzymes market demand, enabling the creation of customized enzymes tailored for specific industrial needs.
The AI-generated enzymes market is further boosted by the growing investment in AI-driven biotechnological research, particularly in healthcare and environmental applications. Companies are also using AI to optimize enzyme stability, improve yield, and reduce production costs. For instance, in April 2022, Israeli startup Enzymit secured USD 5 million in funding to advance its AI platform for designing novel enzymes. This technology aims to reduce production costs of ingredients such as allulose, a non-nutritive sweetener, by making its production cost-competitive with sugar. Therefore, as AI technology continues to evolve, the market is poised for significant transformation, offering innovative solutions to enhance efficiency, sustainability, and cost-effectiveness for multiple industries.
To Understand More About this Research: Request a Free Sample Report
AI-Generated Enzymes Market Dynamics
Growing Investments in AI-Driven Biotechnology
Growing investments in AI-driven biotechnology are playing a key role in driving the AI-generated enzymes market growth as more companies and research institutions receive funding to develop innovative enzyme solutions. Increased financial support from both private and public sectors is advancing the research by improving enzyme design and expanding commercial applications. For example, in January 2022, French biotech company DNA Script raised USD 200 million to advance its enzymatic DNA synthesis technology using AI-driven approaches. This funding helps develop more efficient enzyme-based synthesis methods, revolutionizing genetic research and bio manufacturing. Similarly, Ginkgo Bioworks has developed an AI tool, Owl, to improve enzyme reaction efficiency, demonstrating the latest AI-generated enzymes market trends. This surge in investment is contributing to the market expansion, making advanced enzyme solutions more available across industries such as healthcare, food processing, and biofuels.
Expanding Applications Across Industries
The expanding applications of AI-generated enzymes across multiple industries are significantly driving the AI-generated enzymes market. These advanced enzymes are now widely used in healthcare, agriculture, industrial biotechnology, and environmental sustainability, creating new opportunities for innovation and efficiency. In healthcare, AI-generated enzymes are being used for drug development and diagnostics. For example, in 2023, researchers at Shanghai Jiao Tong University successfully applied AI-driven enzyme design to enhance enzyme stability, making them more effective in medical applications. This aligns with the latest market trends, where AI is revolutionizing biopharmaceutical development.
In agriculture, AI-generated enzymes are improving crop protection and soil health. Enzymes designed through AI are used to develop eco-friendly pesticides and fertilizers, reducing the reliance on chemical-based solutions. This presents a major AI-generated enzymes market opportunity as sustainable agriculture practices gain popularity. Thus, the growing integration of AI-generated enzymes in healthcare, agriculture, and other sectors is driving the market growth.
AI-Generated Enzymes Market Segment Insights
AI-Generated Enzymes Market Assessment by Application
On the basis of application, the AI-generated enzymes market is segmented into food & beverage, pharmaceuticals & healthcare, agriculture, biotechnology & research, and others. In 2024, the food & beverage segment held the largest AI-generated enzymes market share. This dominance is due to the industry's rapid adoption of artificial intelligence to innovate and optimize product development processes. McCormick & Company, with IBM, developed an AI-powered platform for designing innovative spice blends and seasonings. This AI-driven approach analyzes vast amounts of data on consumer preferences and flavor combinations, enabling McCormick to accelerate product development and introduce innovative flavors that cater to evolving tastes. This strategic move has positioned McCormick to meet the increasing demand for personalized and diverse flavor options, thereby contributing to the overall market growth.
AI-Generated Enzymes Market Evaluation by Type Insights
The AI-generated enzymes market segmentation, based on type, includes industrial enzymes, therapeutic enzymes, and others. In 2024, the industrial enzymes segment accounted significant market share due to the extensive application of these enzymes across various sectors, including food and beverages, detergents, animal feed, and biofuels. The versatility and efficiency of industrial enzymes have led to their widespread adoption. In April 2024, Prozomix and Ginkgo Bioworks collaborated to develop next-generation enzyme plates for sustainable active pharmaceutical ingredient (API) manufacturing. This partnership combines Ginkgo's advanced enzyme services and AI/machine learning models with Prozomix's extensive enzyme libraries and manufacturing expertise, aiming to enhance the efficiency and sustainability of API production. Such collaborations represent current market trends, where AI-driven enzyme design accelerates innovation and application across industries. Therefore, industrial enzymes segment will continue to grow due to its broad applications, increasing demand for sustainable solutions, and AI-driven innovations that enhance enzyme efficiency and functionality.
AI-Generated Enzymes Market Regional Analysis
By region, the study provides AI-generated enzymes market insights into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. North America held a considerable share of the global market in 2024, driven by the region's robust biotechnology sector, substantial investments in research and development, and the early adoption of advanced technologies. The presence of leading biotech firms, coupled with a supportive regulatory environment, has accelerated innovation and commercialization in the region. Additionally, the integration of AI in enzyme engineering has significantly improved efficiency, reducing enzyme optimization timelines by 70% within the food and beverage industry. Companies such as Neoncorte Bio are leveraging machine learning models to enhance enzyme discovery and optimization, lowering production costs while meeting evolving consumer and regulatory demands. These advancements have further fueled AI-generated enzymes market growth, positioning North America as a leader in enzyme-based solutions across various industries, including healthcare, agriculture, and industrial biotechnology.
The AI-generated enzymes market in Asia Pacific is projected to grow rapidly during the projection period. This growth is driven by the region's expanding industrial sector, rising investments in biotechnology and artificial intelligence research, and increasing awareness of sustainable practices. Rising investments in biotechnology and artificial intelligence research are promoting innovation in enzyme development. For example, in March 2025, India's Department of Biotechnology announced a funding initiative to support AI-driven biotech startups by promoting the development of novel enzyme solutions. Moreover, the increasing awareness of sustainable practices has led industries to adopt eco-friendly enzymes, aligning with global environmental goals and further propelling the market growth.
AI-Generated Enzymes Market – Key Players and Competitive Insights
The AI-generated enzymes market is highly competitive, driven by increasing demand for efficient biocatalysts across industries such as pharmaceuticals, food processing, and biofuels. Leading companies focus on leveraging artificial intelligence to accelerate enzyme discovery, enhance stability, and optimize production costs. Advancements in AI-powered protein engineering and machine learning-based enzyme optimization are key factors shaping the competitive landscape. Major players in the market include Generate:Biomedicines, Codexis, Google DeepMind, Novozymes, Ginkgo Bioworks, Insilico Medicine, Arzeda, Atomwise, ProteinQure, Biomatter Designs, and others.
Novozymes is a global leader in biosolutions, specializing in the development of industrial enzymes and microorganisms for various applications, including agriculture, food processing, biofuels, and pharmaceuticals. Company is headquartered in Denmark and focuses on sustainability-driven innovation, leveraging biotechnology to improve efficiency and reduce environmental impact. Novozymes plays a key role in the AI-generated enzymes market, utilizing artificial intelligence to enhance enzyme discovery and optimize production processes. In January 2024, Novozymes merged with Chr. Hansen, further strengthening its position in the biotechnology sector. With a commitment to research and development, the company continues to drive market growth, expanding its solutions across industries. Its strategic collaborations and investments in AI-powered enzyme engineering reinforces its leadership in sustainable enzyme innovation.
Ginkgo Bioworks, founded in 2008, is a biotechnology company specializing in synthetic biology and the development of custom-built microbes for various industries, including pharmaceuticals, agriculture, and industrial chemicals. The company uses artificial intelligence and automation to engineer biological systems for commercial applications. Ginkgo Bioworks operates a large-scale biofoundry that accelerates the design and production of enzymes, proteins, and other biological products. It has formed strategic partnerships with major players such as Bayer, Moderna, and Roche to advance research in drug discovery, enzyme engineering, and bio-manufacturing. In July 2022, Ginkgo Bioworks acquired Zymergen to enhance its automation capabilities and expand its synthetic biology platform. With continuous investments in AI-driven biotechnology, the company remains a key innovator in the market.
List of Key Companies in AI-Generated Enzymes Market
- Arzeda
- Atomwise
- Biomatter Designs
- Codexis
- Generate:Biomedicines
- Ginkgo Bioworks
- Google DeepMind
- Insilico Medicine
- Novozymes
- ProteinQure
AI-Generated Enzymes Market Market Developments
October 2024: Codexis announced the development of a novel enzyme in collaboration with Merck. This enzyme is designed to improve the efficiency of a specific pharmaceutical manufacturing process, reducing production costs and environmental impact.
July 2024: Ginkgo Bioworks partnered with Syngenta to accelerate the development of innovative biological solutions in agriculture. The collaboration aims to optimize microbial strains for large-scale production, expediting Syngenta's go-to-market timeline for new biological products.
AI-Generated Enzymes Market Segmentation
By Type Outlook (Revenue, USD Million, 2020–2034)
- Industrial Enzymes
- Therapeutic Enzymes
- Others
By Application Outlook (Revenue, USD Million, 2020–2034)
- Food & Beverage
- Pharmaceuticals & Healthcare
- Agriculture
- Biotechnology & Research
- Others
By Technology Outlook (Revenue, USD Million, 2020–2034)
- Machine Learning-Based Enzyme Design
- Deep Learning & Neural Networks
- Evolutionary Algorithm-Based Enzyme Optimization
By End User Outlook (Revenue, USD Million, 2020–2034)
- Biopharmaceutical Companies
- Research Institutions
- Chemical Industry
- Others
By Regional Outlook (Revenue, USD Million, 2020–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Indonesia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
AI-Generated Enzymes Market Report Scope
|
Report Attributes |
Details |
|
Market Size Value in 2024 |
USD 2,241.00 million |
|
Market Size Value in 2025 |
USD 2,771.89 million |
|
Revenue Forecast in 2034 |
USD 19,407.75 million |
|
CAGR |
24.1%from 2025 to 2034 |
|
Base Year |
2024 |
|
Historical Data |
2020 – 2023 |
|
Forecast Period |
2025 – 2034 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2025 to 2034 |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Trends |
|
Segments Covered |
|
|
Regional scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
FAQ's
The global AI-generated enzymes market size was valued at USD 2,241.00 million in 2024 and is projected to grow to USD 19,407.75 million in 2034.
The global market is projected to register a CAGR of 24.1%from 2025 to 2034.
North America held a considerable share of the global market in 2024.
A few of the key players in the market are Generate:Biomedicines, Codexis, Google DeepMind, Novozymes, Bioworks, Insilico Medicine, Arzeda, Atomwise, ProteinQure, and Biomatter Designs.
The food & beverage segment dominated the market in 2024.
In 2024, the industrial enzymes segment accounted significant market share.
© 2025 Polaris Market Research and Consulting. All rights reserved
